IRIS
D' Incalci, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.949
AS - Asia 9.282
EU - Europa 3.592
SA - Sud America 2.112
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 13
Totale 33.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.556
SG - Singapore 5.703
BR - Brasile 1.756
CN - Cina 1.594
VN - Vietnam 818
FI - Finlandia 748
IT - Italia 609
IE - Irlanda 512
DE - Germania 433
FR - Francia 328
IN - India 271
GB - Regno Unito 259
HK - Hong Kong 211
NL - Olanda 205
CA - Canada 192
AR - Argentina 133
BD - Bangladesh 124
SE - Svezia 93
MX - Messico 84
IQ - Iraq 72
TR - Turchia 63
PL - Polonia 62
RU - Federazione Russa 60
BE - Belgio 58
EC - Ecuador 58
ID - Indonesia 55
ZA - Sudafrica 55
ES - Italia 49
CO - Colombia 47
JP - Giappone 47
MY - Malesia 39
UA - Ucraina 38
PK - Pakistan 31
VE - Venezuela 30
AE - Emirati Arabi Uniti 29
CL - Cile 28
MA - Marocco 27
SA - Arabia Saudita 25
UZ - Uzbekistan 25
IL - Israele 24
PH - Filippine 22
PY - Paraguay 22
JM - Giamaica 20
NG - Nigeria 20
KE - Kenya 19
DO - Repubblica Dominicana 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
EG - Egitto 16
LT - Lituania 16
CR - Costa Rica 15
PA - Panama 15
PE - Perù 15
UY - Uruguay 15
JO - Giordania 14
DZ - Algeria 13
KZ - Kazakistan 13
NI - Nicaragua 13
AZ - Azerbaigian 12
NP - Nepal 12
LB - Libano 10
AL - Albania 9
AT - Austria 9
EE - Estonia 9
HN - Honduras 9
TH - Thailandia 9
AU - Australia 8
PS - Palestinian Territory 8
GR - Grecia 7
LV - Lettonia 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
DK - Danimarca 6
KR - Corea 6
PR - Porto Rico 6
RO - Romania 6
RS - Serbia 6
AO - Angola 5
BY - Bielorussia 5
CH - Svizzera 5
KG - Kirghizistan 5
LU - Lussemburgo 5
NO - Norvegia 5
SN - Senegal 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
OM - Oman 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IR - Iran 3
KH - Cambogia 3
SV - El Salvador 3
Totale 33.097
Salva come PNG Salva come JPEG
Città #
Chandler 2.264
Singapore 2.174
Ashburn 1.839
San Jose 1.818
The Dalles 1.004
New York 745
Helsinki 740
Shanghai 684
Council Bluffs 557
Dublin 509
Dallas 490
Princeton 482
Lawrence 460
Boardman 445
Los Angeles 412
Paris 279
Ho Chi Minh City 270
Santa Clara 260
Beijing 214
Milan 199
Hong Kong 195
Amsterdam 183
Hanoi 175
São Paulo 150
Pune 142
Buffalo 126
Falkenstein 119
London 119
Phoenix 117
Rome 101
North Bergen 85
Seattle 80
Brooklyn 76
Chicago 69
Rio de Janeiro 69
Assago 58
Brussels 56
Atlanta 52
Warsaw 51
Munich 50
Wilmington 48
Boston 46
Montreal 45
Haiphong 44
Frankfurt am Main 43
Belo Horizonte 42
Charlotte 40
San Francisco 39
Curitiba 37
Orem 37
Toronto 37
Da Nang 36
Tokyo 36
Chennai 34
Columbus 34
Mexico City 34
Brasília 33
Johannesburg 32
Miami 32
Stockholm 30
Denver 28
Las Vegas 28
Baghdad 27
Porto Alegre 27
Houston 26
Dhaka 25
Kuala Lumpur 25
Philadelphia 24
Berlin 23
Cleveland 22
Guayaquil 22
Istanbul 21
Tashkent 21
The Bronx 21
Moscow 20
Washington 20
Biên Hòa 19
Naples 19
Guangzhou 18
Kingston 18
Campinas 17
Guarulhos 17
Pasadena 17
San Antonio 17
San Diego 17
Benin City 16
Bogotá 16
Hải Dương 16
Newark 16
Abbeville 15
Detroit 15
Figino 15
Milwaukee 15
Queens 15
Quito 15
Richmond 15
Montevideo 14
Pittsburgh 14
Ribeirão Preto 14
San Mateo 14
Totale 19.441
Salva come PNG Salva come JPEG
Nome #
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma 152
Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics 128
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 127
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 123
A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin 118
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action 118
Reduced expression of the rock inhibitor rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells 111
Mesothelioma. From research to clinical practice 110
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma 110
A prognostic regulatory pathway in stage I epithelial ovarian cancer: new hints for the poor prognosis assessment 110
A Review of Trabectedin (ET-743): A Unique Mechanism of Action 110
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 109
E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models 104
Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB 101
The unique biological features of the marine product Yondelis? (ET-743, trabectedin) are shared by its analog ET-637, which lacks the C ring 100
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors 99
"The Art of Successful Publication" ECCO 13 workshop report 98
3-methyladenine-DNA-glycosylase and O-6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines 98
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 98
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) 98
Clinical pharmacokinetics of the new oral camptothecin gimatecan: The inter-patient variability is related to alpha(1)-acid glycoprotein plasma levels 96
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera 96
A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging 96
A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma 95
A novel taxane active against an orthotopically growing human glioma xenograft 94
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells 94
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia 94
A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer 92
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin 92
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma 92
How Medicines are Born. The Imperfect Science of Drugs 92
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) 91
In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells 91
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia 91
p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth 90
Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors 89
The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism 89
Tumor Associated Macrophages: toward a better understanding of their cancer driver capability in Malignant Pleural Mesothelioma. 89
The combination of yondelis and cisplatin is synergistic against human tumor xenografts 88
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 87
Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue 87
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences 87
Interferon-beta can induce progesterone receptors in human endometrial adenocarcinoma 87
Sequence-specific DNA alkylation of novel tallimustine derivatives 85
Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 85
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis 85
A comprehensive investigation of histotype-specific microRNA and their variants in stage I epithelial ovarian cancers 85
A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS 84
Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters 83
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts 83
Paclitaxel induces significant changes in epidoxorubicin distribution in mice 83
Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study 83
High-performance liquid chromatography tandem mass spectrometry procedure with automated solid phase extraction sample preparation for the quantitative determination of paclitaxel (Taxol (R)) in human plasma 83
Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals 83
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 82
Mechanisms of resistance to alkylating agents 82
Pharmacokinetic of the novel oral camptothecin gimatecan in women with pre-treated advanced breast cancer 81
DISTAMYCIN-A AND TALLIMUSTINE INHIBIT TBP BINDING AND BASAL IN-VITRO TRANSCRIPTION 81
Induction of resistance to Aplidin (R) in a human ovarian cancer cell line related to MDR expression 81
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study 80
Unique features of the mode of action of ET-743 80
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 80
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 80
High dose idarubicin and melphalan after sequential high dose chemotherapy (S-HDC) for lymphomas: Preliminary results of a phase I-II study 80
Optimization of a Luciferase-Expressing Non-Invasive Intrapleural Model of Malignant Mesothelioma in Immunocompetent Mice 79
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 79
Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl-L-Carnitine 79
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy 79
Disruptions in antigen processing and presentation machinery on sarcoma 79
HMGA1 is a new biomarker of liposarcoma progression 78
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus 78
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study 78
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 77
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY AND INDUCTION OF NOVEL IMMUNOGENICITY IN MURINE TUMOR-CELLS TREATED WITH METHYLATING AGENTS 77
Structure elucidation of taxol metabolites by liquid chromatography mass spectrometry and species differences in taxol metabolism - Reply 77
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days 77
Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours 77
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging 77
Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity 77
Investigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticles 77
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus 77
Targeting triple negative breast cancer: Is p53 the answer? 77
Are we close to the clinical development of novel drugs targeting telomeres and telomerase? 77
DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1/CIP1 GENES 76
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER 76
Modulation of gene transcription by natural products - A viable anticancer strategy 76
Pharmacological study on PEG-Asparaginase used in front-line treatment of children with acute lymphoblastic leukemia 76
Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels 76
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer 76
Phase I clinical and pharmacokinetic (PK) study of oral (PO) methoxy-morpholino doxorubicin (PNU 152243) on a single intermittent schedule 75
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 75
Genetic Instability Influences Drug Response in Cancer Cells 75
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 75
The potential impact of marine compounds in the era of targeting therapies 75
Role of homologous recombination in trabectedin-induced DNA damage 75
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup 75
TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells 75
Trabectedin therapy for sarcomas 75
Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers 75
N-Acetylcysteine Augments Surface Thiols and Differentially Modulates Cell Adhesion and Invasion in vitro and Metastatic Potential in vivo of B16F1 Melanoma 75
Totale 8.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 0 7 1 0 0 7 19 5 67 132
2022/20236.459 1.028 151 587 747 428 615 5 690 1.151 575 412 70
2023/20243.814 333 311 940 283 106 679 113 195 39 176 366 273
2024/20254.849 121 16 21 98 128 615 255 271 1.022 1.228 579 495
2025/202613.612 2.014 895 618 1.257 390 687 4.140 544 737 843 537 950
2026/20274.143 550 788 2.082 723 0 0 0 0 0 0 0 0
Totale 33.186